BSP:JNJB34 (USA)  
Johnson & Johnson logo

Johnson & Johnson

R$ 63.14 (-1.03%) Nov 28
P/E:
24.69
P/B:
6.22
Market Cap:
R$ 2.50T ($ 466.27B)
Enterprise V:
R$ 2.50T ($ 465.49B)
Volume:
15.16K
Avg Vol (2M):
33.57K
Also Trade In:
Volume:
15.16K
Market Cap R$:
2.50T
Market Cap $:
466.27B
PE Ratio:
24.69
Avg Vol (2-Month):
33.57K
Enterprise Value R$:
2.50T
Enterprise Value $:
465.49B
PB Ratio:
6.22
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

Financials (Next Earnings Date:2023-01-25 Est.)

BSP:JNJB34's 30-Y Financials

Johnson & Johnson Operating Data

BSP:JNJB34's Complete Operating Data
No operating data availabel for Johnson & Johnson.

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 502,837.528
EPS (TTM) (R$) 2.5
Beta -0.28
Volatility % 20.85
14-Day RSI 58.86
14-Day ATR (R$) 1.539666
20-Day SMA (R$) 61.236
12-1 Month Momentum % 4.03
52-Week Range (R$) 53.3 - 66.01
Shares Outstanding (Mil) 39,217.25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Johnson & Johnson Filings

Document Form Filing Date
No Filing Data

Johnson & Johnson Analysis

Share your research